Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression

NCT04786067 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant Immunosuppression

Interventions

DRUG: Belatacept

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]